IRONWOOD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IRONWOOD
IRONWOOD has two approved drugs.
There are nine US patents protecting IRONWOOD drugs.
There are one hundred and eighty-two patent family members on IRONWOOD drugs in forty-two countries and thirty-five supplementary protection certificates in eighteen countries.
Drugs and US Patents for IRONWOOD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | DISCN | Yes | No | 8,283,369 | ⤷ Try for Free | ⤷ Try for Free | ||||
Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | DISCN | Yes | No | 8,003,681 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-002 | Aug 18, 2017 | DISCN | Yes | No | 8,357,713 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | DISCN | Yes | No | 8,546,436 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | DISCN | Yes | No | 10,183,012 | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for IRONWOOD Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 2135608 | ⤷ Try for Free |
Slovenia | 2135608 | ⤷ Try for Free |
Turkey | 201806828 | ⤷ Try for Free |
Japan | 2014196373 | ⤷ Try for Free |
Malaysia | 172534 | ⤷ Try for Free |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for IRONWOOD Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2135608 | CA 2016 00034 | Denmark | ⤷ Try for Free | PRODUCT NAME: LESINURAD ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU1/15/1080 20160222 |
2217577 | 132019000000023 | Italy | ⤷ Try for Free | PRODUCT NAME: ALLOPURINOLO/LESINURAD, O UN LORO SALE FARMACEUTICAMENTE ACCETTABILE O LORO SALI FARMACEUTICAMENTE ACCETTABILI(DUZALLO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1300, 20180827 |
2135608 | 132016000081719 | Italy | ⤷ Try for Free | PRODUCT NAME: LESINURAD, O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(ZURAMPIC); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1080, 20160222 |
2217577 | SPC/GB19/006 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: LESINURAD, OR A PHARMACEUTICALLY ACCEPTABLE SALT, OR SALTS THEREOF, AND ALLOPURINOL; REGISTERED: UK EU/1/18/1300/001(NI) 20180827; UK EU/1/18/1300/002(NI) 20180827; UK EU/1/18/1300/003(NI) 20180827; UK EU/1/18/1300/004(NI) 20180827 |
2135608 | 1690033-4 | Sweden | ⤷ Try for Free | PRODUCT NAME: LESINURAD, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REG. NO/DATE: EU/1/15/1080 20160222 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.